Analysts forecast that Encompass Health Corp (NYSE:EHC) will report $1.09 billion in sales for the current quarter, according to Zacks. Six analysts have made estimates for Encompass Health’s earnings. The highest sales estimate is $1.13 billion and the lowest is $1.08 billion. Encompass Health reported sales of $1.02 billion during the same quarter last year, which indicates a positive year over year growth rate of 6.9%. The business is scheduled to issue its next quarterly earnings results on Monday, February 25th.
On average, analysts expect that Encompass Health will report full year sales of $4.27 billion for the current year, with estimates ranging from $4.26 billion to $4.31 billion. For the next year, analysts expect that the business will post sales of $4.53 billion, with estimates ranging from $4.49 billion to $4.56 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research firms that follow Encompass Health.
EHC has been the topic of several research analyst reports. Mizuho reaffirmed a “buy” rating and issued a $82.00 price target on shares of Encompass Health in a report on Thursday, July 26th. Credit Suisse Group upped their price target on shares of Encompass Health from $66.00 to $80.00 and gave the stock an “outperform” rating in a report on Thursday, July 26th. Finally, Piper Jaffray Companies raised shares of Encompass Health from a “neutral” rating to an “overweight” rating in a report on Thursday, July 26th. One analyst has rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. Encompass Health currently has an average rating of “Buy” and an average target price of $73.00.
Shares of Encompass Health stock traded down $0.71 during trading on Monday, hitting $73.22. The stock had a trading volume of 774,465 shares, compared to its average volume of 862,592. The stock has a market cap of $7.26 billion, a P/E ratio of 26.53, a PEG ratio of 1.86 and a beta of 0.49. Encompass Health has a 12 month low of $47.32 and a 12 month high of $82.46. The company has a debt-to-equity ratio of 1.58, a quick ratio of 1.05 and a current ratio of 1.05.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, January 15th. Stockholders of record on Wednesday, January 2nd will be issued a $0.27 dividend. The ex-dividend date is Monday, December 31st. This represents a $1.08 annualized dividend and a dividend yield of 1.48%. Encompass Health’s payout ratio is currently 39.13%.
About Encompass Health
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Featured Story: Short Selling
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.